Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) was the recipient of a significant decline in short interest in February. As of February 13th, there was short interest totaling 3,356 shares, a decline of 60.0% from the January 29th total of 8,388 shares. Based on an average daily volume of 67,768 shares, the short-interest ratio is currently 0.0 days. Based on an average daily volume of 67,768 shares, the short-interest ratio is currently 0.0 days.
Raia Drogasil Trading Down 1.3%
Shares of OTCMKTS RADLY traded down $0.07 during mid-day trading on Friday, reaching $5.00. The company had a trading volume of 4,469 shares, compared to its average volume of 26,123. Raia Drogasil has a twelve month low of $2.17 and a twelve month high of $5.34. The stock’s 50 day moving average is $4.73 and its 200-day moving average is $4.10.
Raia Drogasil Company Profile
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
See Also
- Five stocks we like better than Raia Drogasil
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
